Table 1.
GEO Dataset | Country | Year | ADC | SCC | NSCLC * | Controls | Sample Type in Patients | Sample Type in Controls | Platform | SETDB1 ID | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|
GSE32867 | Canada | 2012 | 58 | 58 | Cancer tissue | Adjacent non-cancerous tissues | Illumina Human WG-6 v3.0 Expression BeadChips | ILMN_1718207 | [25] | ||
GSE18842 | Spain | 2010 | 14 | 31 | 46 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Genome U133 Plus 2.0 Array | 203155_at | [26] | |
GSE19804 | Taiwan | 2010 | 60 | 60 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix GeneChip Human Genome U133 plus array | 203155_at | [27] | ||
GSE103512 | Germany | 2017 | 30 | 25 | 14 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix HT-U133plus-2-PM microarrays | 203155_PM_at | [28] | |
GSE63459 | USA/Japan | 2015 | 33 | 32 | Cancer tissue | Adjacent non-cancerous tissues | Illumina HumanRef-8 v3 Expression Beadchip arrays | ILMN_1718207 | [29] | ||
GSE75037 | USA | 2016 | 83 | 83 | Cancer tissue | Adjacent non-cancerous tissues | Illumina BeadChip array HumanWG-6 V3 | ILMN_1718207 | [30] | ||
GSE33532 | Germany | 2014 | 10 | 4 | 6 | 20 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix U133 Plus 2.0 arrays | 203155_at | [31] |
GSE44077 | USA | 2013 | 14 | 5 | 2 | 21 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] | 7905258 | [32] |
GSE43458 | USA | 2013 | 80 | 30 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] | 7905258 | [33] | ||
GSE21933 | USA/Taiwan | 2012 | 11 | 10 | 21 | Cancer tissue | Adjacent non-cancerous tissues | Phalanx Human OneArray | PH_hs_0023897 | [34] | |
GSE31552 | USA | 2014 | 21 | 9 | 2 | 32 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] | 7905258 | [35] |
GSE10072 | Italy | 2008 | 58 | 49 | Cancer tissue | Healthy lung tissues | Affymetrix Human Genome U133A Array | 203155_at | [36] | ||
GSE4115 | USA | 2007 | 90 | Cancer tissue | Healthy lung tissues | Affymetrix Human Genome U133A Array | 203155_at | [37] | |||
GSE31547 | USA | 2018 | 30 | 20 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Genome U133A Array | 203155_at | Notpublished | ||
GSE7670 | Taiwan | 2007 | 26 | 27 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Genome U133A Array | 203155_at | [38] | ||
GSE2514 | USA | 2005 | 20 | 19 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix GeneChip microarray (HGU95Av2) | 34189_at | [39] | ||
GSE11117 | Switzerland | 2010 | 13 | 14 | 15 | Cancer tissue | Chronic inflammatory lung disease tissues | Nova Chip microarrays (Novartis) | H200002955 | [40] | |
GSE1987 | Israel | 2006 | 28 | 9 | Cancer tissue | Healthy lung tissues | Affymetrix Human Genome U95A Array | 34189_at | [41] | ||
GSE19188 | Netherlands | 2010 | 45 | 27 | 65 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Genome U133 Plus 2.0 Array | 203155_at | [42] | |
GSE74706 | Germany | 2016 | 10 | 8 | 18 | Cancer tissue | Adjacent non-cancerous tissues | Agilent-026652 Whole Human Genome Microarray 4 × 44K v2 | A_23_P126393 | [43] | |
GSE46539 | Taiwan | 2015 | 115 | 115 | Cancer tissue | Adjacent non-cancerous tissues | Illumina WG-DASL HumanRef8 v3 or HumanHT12 v4 BeadChip | ILMN_1718207 | [44] | ||
GSE2088 | Japan | 2011 | 9 | 48 | 30 | Cancer tissue | Healthy lung tissues | CHUGAI 41K microarray | 11758 | [45] | |
GSE12428 | Netherlands | 2008 | 34 | 28 | Cancer tissue | Adjacent non-cancerous tissues/Healthy lung tissues | Agilent-012391 Whole Human Genome Oligo Microarray G4112A | 7231 | [46] | ||
GSE27262 | Taiwan | 2012 | 25 | 25 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Genome U133 Plus 2.0 Array | 203155_at | [47] | ||
GSE101929 | USA | 2017 | 25 | 25 | Cancer tissue | Adjacent non-cancerous tissues | Affymetrix Human Genome U133 Plus 2.0 Array | 203155_at | [48] |
* Non-small cell lung carcinoma (NSCLC): Patients are not classified as adenocarcinoma (ADC) or squamous cell carcinoma (SCC).